Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic T Moore

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
The Oncologist|June 26, 2025
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinomaMichael S Lee, Joseph Chao, Mary F Mulcahy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 30, 2005
High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotypeAmy L Lark, Chad A Livasy, Lynn Dressler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancerThomas E Stinchcombe, David E Morris, Carrie B Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancerThomas E Stinchcombe, Harry D Harper, Thomas A Hensing, et al.
Annals of Surgical Oncology|March 29, 2011
Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancerMichael O Meyers, Nancy Klauber-Demore, David W Ollila, et al.
Clinical Colorectal Cancer|January 28, 2012
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinomaMichael A Morse, Brent A Hanks, Paul Suhocki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypesLisa A Carey, E Claire Dees, Lynda Sawyer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapyRandall J Kimple, Nancy Klauber-DeMore, Cherie M Kuzmiak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignanciesThomas C Shea, Rebecca Bruner, Joseph M Wiley, et al.
Annals of Surgical Oncology|November 10, 2010
Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancerRandall J Kimple, Nancy Klauber-DeMore, Cherie M Kuzmiak, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
The Oncologist|June 26, 2025
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinomaMichael S Lee, Joseph Chao, Mary F Mulcahy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 30, 2005
High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotypeAmy L Lark, Chad A Livasy, Lynn Dressler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancerThomas E Stinchcombe, David E Morris, Carrie B Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancerThomas E Stinchcombe, Harry D Harper, Thomas A Hensing, et al.
Annals of Surgical Oncology|March 29, 2011
Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancerMichael O Meyers, Nancy Klauber-Demore, David W Ollila, et al.
Clinical Colorectal Cancer|January 28, 2012
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinomaMichael A Morse, Brent A Hanks, Paul Suhocki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypesLisa A Carey, E Claire Dees, Lynda Sawyer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapyRandall J Kimple, Nancy Klauber-DeMore, Cherie M Kuzmiak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignanciesThomas C Shea, Rebecca Bruner, Joseph M Wiley, et al.
Annals of Surgical Oncology|November 10, 2010
Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancerRandall J Kimple, Nancy Klauber-DeMore, Cherie M Kuzmiak, et al.
Pageof 11